We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

136 hedge funds and large institutions have $395M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2016 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

88% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 33

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

1% more funds holding

Funds holding: 134 → 136 (+2)

5% less capital invested

Capital invested by funds: $418M → $395M (-$22.1M)

Holders
136
Holders Change
+2
Holders Change %
+1.49%
% of All Funds
3.62%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
22
Increased
62
Reduced
33
Closed
19
Calls
$426K
Puts
–
Net Calls
+$426K
Net Calls Change
+$425K

Top Buyers

Rank Fund Capital Flow
1
CC
Carlson Capital
Texas
+$16.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
+$9.69M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.04M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$6.24M
5
PCM
Penn Capital Management
Pennsylvania
+$4.69M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$27.8M
2
Franklin Resources
Franklin Resources
California
-$17.1M
3
TA
Tamarack Advisers
California
-$7.16M
4
EAM
EverPoint Asset Management
Connecticut
-$7.01M
5
Millennium Management
Millennium Management
New York
-$5.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$3.36M +$612K +43,650 +19%
Prudential Financial
27
Prudential Financial
New Jersey
$3.23M +$438K +31,200 +13%
Deutsche Bank
28
Deutsche Bank
Germany
$2.82M +$666K +47,461 +26%
FHAM
29
Folger Hill Asset Management
New York
$2.76M – – –
KA
30
Kerrisdale Advisers
Florida
$2.48M +$2.86M +204,126 New
Fidelity Investments
31
Fidelity Investments
Massachusetts
$2.47M -$359K -25,600 -11%
TC
32
TFS Capital
Pennsylvania
$2.15M +$417K +29,738 +20%
Goldman Sachs
33
Goldman Sachs
New York
$2.04M +$724K +51,622 +44%
Principal Financial Group
34
Principal Financial Group
Iowa
$2M +$93K +6,634 +4%
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$1.8M +$2.08M +148,114 New
RJA
36
Raymond James & Associates
Florida
$1.8M -$7.32K -522 -0.4%
GC
37
Guggenheim Capital
Illinois
$1.64M -$4.56K -325 -0.2%
Morgan Stanley
38
Morgan Stanley
New York
$1.62M -$321K -22,913 -15%
PAMU
39
Pictet Asset Management (UK)
United Kingdom
$1.59M – – –
Point72 Asset Management
40
Point72 Asset Management
Connecticut
$1.44M -$1.03M -73,500 -38%
PCM
41
Piermont Capital Management
Missouri
$1.41M -$323K -23,015 -17%
Ameriprise
42
Ameriprise
Minnesota
$1.36M +$29.1K +2,078 +2%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$1.34M +$1.18M +83,905 +318%
Invesco
44
Invesco
Georgia
$1.31M +$115K +8,167 +8%
RHJA
45
Rice Hall James & Associates
California
$1.26M +$8.41K +600 +0.6%
TCIM
46
TIAA CREF Investment Management
New York
$1.26M +$407K +29,051 +39%
JAM
47
JW Asset Management
Florida
$1.24M – – –
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.21M +$103K +7,332 +8%
PVI
49
Pura Vida Investments
New York
$1.09M +$1.26M +89,713 New
BIM
50
BlackRock Investment Management
Delaware
$1.04M -$421 -30 -0%
1
2
3 4 5

SGNT Hedge Fund Activity: Q1 2016 in Review

136 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2016, worth a combined $395M — down 5.3% from $418M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGNT positions and 19 closed out — a net gain of 3 holders — while 62 added to existing stakes and 33 trimmed.

The largest buyer was Carlson Capital, opening a new position worth an estimated $16.7M. The largest seller was HealthCor Management, exiting entirely with an estimated $27.8M sold.

  • 136 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2016, up from 134 in Q4 2015.
  • Funds reported $395M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2016, down 5.3% quarter-over-quarter.
  • 22 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2016 and 19 closed out, a net change of +3 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2016 was Carlson Capital, an estimated $16.7M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2016 was HealthCor Management, an estimated $27.8M sold.

Based on aggregated 13F filings for Q1 2016.